| Price | 527.50p on 29-05-2026 at 16:30:01 |
|---|---|
| Change | 22.50p 4.46% |
| Buy | 550.00p |
| Sell | 505.00p |
| Last Trade: | Sell 500.00 at 516.00p |
| Day's Volume: | 3,733 |
| Last Close: | 527.50p |
| Open: | 505.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 505.00p - 530.00p |
| 52wk Range: | 425.00p - 1,110.00p |
| Market Capitalisation: | £81.68m |
| VWAP: | 528.12483p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 500 | 516.00p | Ordinary |
15:39:23 - 29-May-26 |
| Buy* | 250 | 530.00p | SI Trade |
12:04:28 - 29-May-26 |
| Unknown* | -250 | 530.00p | SI Trade Correction |
12:04:28 - 29-May-26 |
| Unknown* | 0 | 540.00p | SI Trade |
12:03:58 - 29-May-26 |
| Unknown* | 2,500 | 530.00p | Ordinary |
12:03:16 - 29-May-26 |
| Buy* | 200 | 530.00p | Ordinary |
12:02:24 - 29-May-26 |
| Buy* | 100 | 530.00p | Ordinary |
11:41:52 - 29-May-26 |
| Buy* | 375 | 530.00p | Ordinary |
09:37:15 - 29-May-26 |
| Unknown* | 0 | 500.00p | SI Trade |
09:37:13 - 29-May-26 |
| Buy* | 9 | 530.00p | Ordinary |
08:38:44 - 29-May-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd May 2026 9:10 am | PRN | Director Dealing |
| 20th May 2026 7:02 am | PRN | Final Results and Notice of AGM |
| 20th May 2026 7:00 am | PRN | 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial |
| 14th May 2026 7:00 am | PRN | Appointment of Chief Financial Officer and Board Changes |
| 11th May 2026 7:00 am | PRN | 4basebio Launches Enzymatic ssDNA Platform |
| 31st Mar 2026 7:00 am | PRN | Lease of Manufacturing Facility |
| 12th Mar 2026 7:00 am | PRN | Appointment of COO |
| 3rd Mar 2026 7:00 am | PRN | Appointment of CCO |
| 16th Feb 2026 7:00 am | PRN | Director Dealing |
| 11th Feb 2026 3:58 pm | PRN | Director Dealing |
